v3.26.1
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (3,927,240) $ (3,068,345)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 37,692 34,055
Loss on lease modification 2,163 0
Amortization of right-of-use assets 78,961 83,360
Stock based compensation 6,149 30,402
Change in fair value of warrant liability 0 (143)
Gain on disposal of property and equipment 0 (1,175)
Impairment of intangible assets and deferred patent costs 623,532 0
Changes in operating assets and liabilities:    
Accounts receivable (4,196) 233
Prepaid expenses 255,303 5,771
Other assets 174 0
Tax credits receivable (9,001) (1,383)
Income tax payable (6,256) (11,572)
Accounts payable and accrued expenses 542,064 (65,039)
Operating lease liability (76,649) (77,926)
Net cash used in operating activities (2,477,304) (3,071,762)
Cash flows from investing activities:    
Purchases of property and equipment (14,928) 0
Proceeds from sale of property and equipment 0 3,153
Deferred patent costs (22,211) (24,839)
Net cash used in investing activities (37,139) (21,686)
Cash flows from financing activities    
Principal payments on finance leases (4,261) (3,872)
Proceeds from public offerings, net 0 1,749,311
Proceeds from private placement, net 10,384,194 0
Proceeds from equity line of credit 215,950 0
Repayment of insurance premium financing liability (98,520) 0
Net cash provided by financing activities 10,497,363 1,745,439
Net change in cash and cash equivalents 7,982,920 (1,348,009)
Cash and cash equivalents at beginning of period 2,068,083 4,554,719
Cash and cash equivalents at end of period $ 10,051,003 $ 3,206,710